
RNS Number : 8383I
Celsius Resources Limited
15 May 2025
15 May 2025
CELSIUS RESOURCES LIMITED ("Celsius" or the "Company")
ASX PROSPECTUS
Further to the announcement of 9 May 2025, Celsius Resources Limited ( Celsius or CLA ) (ASX, AIM:CLA) has today published a prospectus on ASX in connection with the Placement options (the "Prospectus").
The Prospectus is available on the Company website at https://celsiusresources.com
This announcement has been authorised by the Board of Directors of Celsius Resources Limited.
For further information contact:
|
Celsius Resources Limited
|
|
|
|
Mark van Kerkwijk
|
P: +61 2 8072 1400
E: [email protected]
W: www.celsiusresources.com
|
|
|
Multiplier Media
(Australia Media Contact)
Jon Cuthbert
|
M: +61 402 075 707
E: [email protected]
|
|
|
Beaumont Cornish Limited
(Nominated Adviser)
Roland Cornish/Felicity Geidt/Andrew Price
|
P: +44 (0) 207 628 3396
E: [email protected]
|
|
Zeus Capital Limited
|
|
|
HarryAnsell/JamesJoyce/James Bavister
|
|
|
|
|
|
P: :+44 (0) 20 3 829 5000
|
|
|
|
|
|
Beaumont Cornish Limited ("Beaumont Cornish") is the Company's Nominated Adviser and is authorised and regulated by FCA. Beaumont Cornish's responsibilities as the Company's Nominated Adviser, including a responsibility to advise and guide the Company on its responsibilities under the AIM Rules for Companies and AIM Rules for Nominated Advisers, are owed solely to the London Stock Exchange. Beaumont Cornish is not acting for and will not be responsible to any persons for providing protections afforded to customers of Beaumont Cornish nor for advising them in relation to the proposed arrangements described in this announcement or any matter referred to in it.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
[email protected] or visit
www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy.
END
PDIFIFFAEDIELIE